2014-02-24 07:56:03 - Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Coagulation, Psychiatric Disorders, Tumor Markers, Molecular Blood Typing and Other Testing) - a new market research report on companiesandmarkets.com
The global personalized medicine diagnostics market is expected to grow to a value of over $30 billion by the end of 2018. Diabetes management test and Cancer management test are the leading market in this segment.The global personalized medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012.Personalized Medicine is often defined as "the right treatment for the right person at the right time." Personalized medicine is becoming the
place to be in clinical diagnostics as well and slowly becoming the reality of future in the diagnostics industryReport ScopeThis report provides a comprehensive analysis of the emerging personalized medicine diagnostic market segments, including their dynamics, size, market share, key investors, clinical trials statement, technological trends, company analysis and a realistic future potential for personalized medicine in clinical testing. The report also entails major drivers and challenges of personalized medicine diagnostic market. This 173 page report contains 94 Figures and 16 Tables studies the Personalized Medicine Diagnostics Market.This report contains 12 chapters:- Chapter 1 is Executive Summary
- Chapter 2 contains worldwide personalized medicine diagnostic market & forecast (2011 - 2018). The market includes technological & disease-wise personalized medicine diagnostics market
- Chapter 3 contains worldwide personalized medicine diagnostic market share segment. Segment include Technology, Disease-Wise
- Chapter 4 contains segment-wise technological personalized diagnostic market & forecast (2010 - 2018)
- Chapter 5 contains geographical segment-wise personalized diagnostic market & forecast (2011 - 2018)
- Chapter 6 contains disease-wise personalized diagnostic market share & forecast (2011 - 2018)
- Chapter 7 contains disease-wise personalized diagnostic market & forecast (2011 - 2018)
- Chapter 8 and 9 contains clinical trial statement and key investors in Personalized Diagnostics Medicine Market
- Chapter 10 and 11 contains growth Drivers & Challenges for Personalized Medicine
- Chapter 12 contains company analysis of Personalized Medicine Companies analyzed in this report are:- HistoRx
- A&G Pharmaceuticals Inc
- 20/20 GeneSystems
- Tethys Bioscience
- Genomas Inc
Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Market Research Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Market ..
Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..
Browse all Latest Market Research Reports www.companiesandmarkets.com/Market/All/Market-Research?aCode=f3f ..
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.